Intraoperative Radiotherapy in Brain Malignancies: Indications and Outcomes in Primary and Metastatic Brain Tumors

Despite the continued controversy over defining an optimal delivery mechanism, the critical role of adjuvant radiation in the management of surgically resected primary and metastatic brain tumors remains one of the universally accepted standards in neuro-oncology. Local disease control still ranks a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Christopher P. Cifarelli, Geraldine M. Jacobson
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/071be05c96bd443bace32e02029a851e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:071be05c96bd443bace32e02029a851e
record_format dspace
spelling oai:doaj.org-article:071be05c96bd443bace32e02029a851e2021-11-11T04:48:36ZIntraoperative Radiotherapy in Brain Malignancies: Indications and Outcomes in Primary and Metastatic Brain Tumors2234-943X10.3389/fonc.2021.768168https://doaj.org/article/071be05c96bd443bace32e02029a851e2021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fonc.2021.768168/fullhttps://doaj.org/toc/2234-943XDespite the continued controversy over defining an optimal delivery mechanism, the critical role of adjuvant radiation in the management of surgically resected primary and metastatic brain tumors remains one of the universally accepted standards in neuro-oncology. Local disease control still ranks as a significant predictor of survival in both high-grade glioma and treated intracranial metastases with radiation treatment being essential in maximizing tumor control. As with the emergence and eventual acceptance of cranial stereotactic radiosurgery (SRS) following an era dominated by traditional radiotherapy, evidence to support the use of intraoperative radiotherapy (IORT) in brain tumors requiring surgical intervention continues to accumulate. While the clinical trial strategies in treating glioblastoma with IORT involve delivery of a boost of cavitary radiation prior to the planned standard external beam radiation, the use of IORT in metastatic disease offers the potential for dose escalation to the level needed for definitive adjuvant radiation, eliminating the need for additional episodes of care while providing local control equal or superior to that achieved with SRS in a single fraction. In this review, we explore the contemporary clinical data on IORT in the treatment of brain tumors along with a discussion of the unique dosimetric and radiobiological factors inherent in IORT that could account for favorable outcome data beyond those seen in other techniques.Christopher P. CifarelliChristopher P. CifarelliGeraldine M. JacobsonFrontiers Media S.A.articleIORTbrain metastasesglioblastomaradiotherapylocal controlradiobiologyNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENFrontiers in Oncology, Vol 11 (2021)
institution DOAJ
collection DOAJ
language EN
topic IORT
brain metastases
glioblastoma
radiotherapy
local control
radiobiology
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle IORT
brain metastases
glioblastoma
radiotherapy
local control
radiobiology
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Christopher P. Cifarelli
Christopher P. Cifarelli
Geraldine M. Jacobson
Intraoperative Radiotherapy in Brain Malignancies: Indications and Outcomes in Primary and Metastatic Brain Tumors
description Despite the continued controversy over defining an optimal delivery mechanism, the critical role of adjuvant radiation in the management of surgically resected primary and metastatic brain tumors remains one of the universally accepted standards in neuro-oncology. Local disease control still ranks as a significant predictor of survival in both high-grade glioma and treated intracranial metastases with radiation treatment being essential in maximizing tumor control. As with the emergence and eventual acceptance of cranial stereotactic radiosurgery (SRS) following an era dominated by traditional radiotherapy, evidence to support the use of intraoperative radiotherapy (IORT) in brain tumors requiring surgical intervention continues to accumulate. While the clinical trial strategies in treating glioblastoma with IORT involve delivery of a boost of cavitary radiation prior to the planned standard external beam radiation, the use of IORT in metastatic disease offers the potential for dose escalation to the level needed for definitive adjuvant radiation, eliminating the need for additional episodes of care while providing local control equal or superior to that achieved with SRS in a single fraction. In this review, we explore the contemporary clinical data on IORT in the treatment of brain tumors along with a discussion of the unique dosimetric and radiobiological factors inherent in IORT that could account for favorable outcome data beyond those seen in other techniques.
format article
author Christopher P. Cifarelli
Christopher P. Cifarelli
Geraldine M. Jacobson
author_facet Christopher P. Cifarelli
Christopher P. Cifarelli
Geraldine M. Jacobson
author_sort Christopher P. Cifarelli
title Intraoperative Radiotherapy in Brain Malignancies: Indications and Outcomes in Primary and Metastatic Brain Tumors
title_short Intraoperative Radiotherapy in Brain Malignancies: Indications and Outcomes in Primary and Metastatic Brain Tumors
title_full Intraoperative Radiotherapy in Brain Malignancies: Indications and Outcomes in Primary and Metastatic Brain Tumors
title_fullStr Intraoperative Radiotherapy in Brain Malignancies: Indications and Outcomes in Primary and Metastatic Brain Tumors
title_full_unstemmed Intraoperative Radiotherapy in Brain Malignancies: Indications and Outcomes in Primary and Metastatic Brain Tumors
title_sort intraoperative radiotherapy in brain malignancies: indications and outcomes in primary and metastatic brain tumors
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/071be05c96bd443bace32e02029a851e
work_keys_str_mv AT christopherpcifarelli intraoperativeradiotherapyinbrainmalignanciesindicationsandoutcomesinprimaryandmetastaticbraintumors
AT christopherpcifarelli intraoperativeradiotherapyinbrainmalignanciesindicationsandoutcomesinprimaryandmetastaticbraintumors
AT geraldinemjacobson intraoperativeradiotherapyinbrainmalignanciesindicationsandoutcomesinprimaryandmetastaticbraintumors
_version_ 1718439558065946624